Fast production of highly concentrated reactive [18F] fluoride for aliphatic and aromatic nucleophilic radiolabelling

Tetrahedron Letters

Volumn 51, Issue 1, 2010, Pages 64-66

  Aerts, Joël ^a   Voccia, Samuel ^b   Lemaire, Christian ^a   Giacomelli, Fabrice ^a   Goblet, David ^a   Thonon, David ^a   Plenevaux, Alain ^a   Warnock, Geoffrey ^a   Luxen, André ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b Trasis SA   (Belgium)

Author keywords

F 18; Fluoride; Nucleophilic substitution; Positron emission tomography; Radiofluorination; Radiopharmaceuticals; SPE

Indexed keywords

ALIPHATIC COMPOUND; ALKYL GROUP; AROMATIC COMPOUND; FLUORINE 18; NUCLEOPHILE; QUATERNARY AMMONIUM DERIVATIVE; RADIOPHARMACEUTICAL AGENT;

ARTICLE; CYCLOTRON; EVAPORATION; ISOTOPE LABELING; POSITRON EMISSION TOMOGRAPHY; PRECURSOR; SYNTHESIS;

EID: 70849122728     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tetlet.2009.10.085     Document Type: Article

References (26)

1. Ametamey S., Honer M., and Schubiger P. Chem. Rev. 108 (2008) 1501-1516
2. Levin C. Eur. J. Nucl. Med. Mol. Imaging 32 (2005) S325-S345
3. Padgett H., Schmidt D., Luxen A., Bida G., Satyamurthy N., and Barrio J. Appl. Radiat. Isot. 40 (1989) 433-445
4. Lemaire C., Damhaut P., Lauricella B., Mosdzianowski C., Morelle J.-L., Monclus M., Van Naemen J., Mulleneers E., Aerts J., Plenevaux A., Brihaye C., and Luxen A. J. Labelled Compd. Radiopharm. 45 (2002) 435-447
5. Tewson T.J. Nucl. Med. Biol. 6 (1989) 533-551
6. Nutt R., Vento L., and Ridinger M. Clin. Pharmacol. Ther. 81 (2007) 792-795
7. Lee C., Sui G., Elizarov A., Shu C., Shin Y., Dooley A., Huang J., Daridon A., Wyatt P., Stout D., Kolb H., Witte O., Satyamurthy N., Heath J., Phelps M., Quake S., and Tseng H. Science 310 (2005) 1793-1796
8. Hamacher K., Coenen H.H., and Stoecklin G. J. Nucl. Med. 27 (1986) 235-238
9. Stone-Elander S., and Elander N. J. Labelled Compd. Radiopharm. 45 (2002) 715-746
10. Kim D.W., Choe Y.S., and Chi D.Y. Nucl. Med. Biol. 30 (2003) 345-350
11. Kim D.W., Ahn D.-S., Oh Y.-H., Lee S., Kil H.S., Oh S.J., Lee S.J., Kim J.S., Ryu J.S., Moon D.H., and Chi D.Y. J. Am. Chem. Soc. 128 (2006) 16394-16397
12. Bejot R., Fowler T., Carroll L., Boldon S., Moore J.E., Declerck J., and Gouverneur V. Angew. Chem., Int. Ed. 48 (2009) 586-589
13. Watson D.A., Su M.S., Teverovskiy G., Zhang Y., García-Fortanet J., Kinzel T., and Buchwald S.L. Science 325 (2009) 1661-1664
14. Toorongian S., Mulholland G., Jewett D., Bachelor M., and Kilbourn M. Nucl. Med. Biol. 17 (1990) 273-279
15. Hamacher K., Hirschfelder T., and Coenen H. Appl. Radiat. Isot. 56 (2002) 519-523
16. Jewett D., Toorongian S., Mulholland G., Watkins G., and Kilbourn M. Appl. Radiat. Isot. 11 (1988) 1109-1111
17. 10Br) was dissolved in 1 ml of ACN. The solution was added to 100 mg of N-vinyl lactame/divinylbenzene copolymer sorbent, a typical example is Waters Oasis™ HLB. The suspension was triturated until complete evaporation of the solvent.
18. 3 in water and rinsed with 3 ml of water. When using a bicarbonate salt, the functionalised sorbent was used without conditioning.
19. - was passed through the extraction cartridge (at 1 ml/min). The cartridge was dried for 4 min with a nitrogen flow (10 l/min, upstream pressure 3.25 bar). The radioactivity was eluted with 1 ml ACN (dried on molecular sieves, <100 ppm water).
20. A Waters Sep-pak® QMA cartridge was eluted with a mixture of equal volumes of potassium carbonate in water (35 mg/1.5 ml) and Kryptofix K222 in ACN (110 mg/1.5 ml). A 500 μL aliquot was submitted to an azeotropic drying (95 °C, nitrogen flow, 5 min). The residue was dissolved in 1 ml of dry ACN (water <100 ppm) and the mixture was heated at 100 °C in capped reactor to simulate a labelling step. After cooling, the residual water concentration was estimated by Karl Fisher titration (541 ± 118 ppm, n = 3).
21. Landini D., Maia A., and Rampoldi A. J. Org. Chem. 54 (1989) 328-332
22. 18F] incorporation. The yields were calculated from the chromatography results and the transferred percentages of activity.
23. 18F]fallypride for imaging dopamine D2 receptors: Nice. In World Molecular Imaging Congress, 2008.
24. Lemaire C., Guillaume M., Cantineau R., and Christiaens L. J. Nucl. Med. 31 (1990) 1247-1251
25. Li X., Link J.M., Stekhova S., Yagle K.J., Smith C., Krohn K.A., and Tait J.F. Bioconjugate Chem. 19 (2008) 1684-1688
26. Le Bars D., Lemaire C., Ginovart N., Plenevaux A., Aerts J., Brihaye C., Hassoun W., Leviel V., Mekhsian P., Weissmann D., Pujol J., Luxen A., and Comar D. Nucl. Med. Biol. 25 (1998) 343-350